154 related articles for article (PubMed ID: 20494667)
1. Echocardiographic follow-up of treated patients with carcinoid syndrome.
Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.
Denney WD; Kemp WE; Anthony LB; Oates JA; Byrd BF
J Am Coll Cardiol; 1998 Oct; 32(4):1017-22. PubMed ID: 9768727
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with progression of carcinoid heart disease.
Møller JE; Connolly HM; Rubin J; Seward JB; Modesto K; Pellikka PA
N Engl J Med; 2003 Mar; 348(11):1005-15. PubMed ID: 12637610
[TBL] [Abstract][Full Text] [Related]
4. Assessment of patent foramen ovale in carcinoid heart disease.
Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
[TBL] [Abstract][Full Text] [Related]
5. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Pellikka PA; Tajik AJ; Khandheria BK; Seward JB; Callahan JA; Pitot HC; Kvols LK
Circulation; 1993 Apr; 87(4):1188-96. PubMed ID: 7681733
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the development and progression of carcinoid heart disease.
Bhattacharyya S; Toumpanakis C; Chilkunda D; Caplin ME; Davar J
Am J Cardiol; 2011 Apr; 107(8):1221-6. PubMed ID: 21296329
[TBL] [Abstract][Full Text] [Related]
7. Progression of Carcinoid Heart Disease in the Modern Management Era.
Baron E; Szymanski C; Hergault H; Lepère C; Dubourg O; Hauguel-Moreau M; Mansencal N
J Am Heart Assoc; 2021 Dec; 10(23):e020475. PubMed ID: 34816734
[TBL] [Abstract][Full Text] [Related]
8. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.
Mansencal N; McKenna WJ; Mitry E; Beauchet A; Pellerin D; Rougier P; Dubourg O
Am J Cardiol; 2010 Feb; 105(4):527-31. PubMed ID: 20152249
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, one-year-incidence and predictors of carcinoid heart disease.
Mattig I; Franke MR; Pschowski R; Brand A; Stangl K; Knebel F; Dreger H
Cardiovasc Ultrasound; 2023 Sep; 21(1):18. PubMed ID: 37752548
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic diagnosis in carcinoid heart disease.
Wonnink-De JW; Knibbeler-Van RC; Van der Heul C; Pasteuning WH
Neth J Med; 2002 May; 60(4):181-5. PubMed ID: 12164398
[TBL] [Abstract][Full Text] [Related]
12. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular abnormalities in patients with a carcinoid syndrome.
Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
[TBL] [Abstract][Full Text] [Related]
14. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.
Lundin L; Norheim I; Landelius J; Oberg K; Theodorsson-Norheim E
Circulation; 1988 Feb; 77(2):264-9. PubMed ID: 2448062
[TBL] [Abstract][Full Text] [Related]
15. Incidence and evolution of carcinoid syndrome in the heart.
Moyssakis IE; Rallidis LS; Guida GF; Nihoyannopoulos PI
J Heart Valve Dis; 1997 Nov; 6(6):625-30. PubMed ID: 9427132
[TBL] [Abstract][Full Text] [Related]
16. The tricuspid valve in carcinoid syndrome. An echocardiographic study.
Taber M; Askenazi J; Ribner H; Kumar S; Lesch M
Arch Intern Med; 1983 May; 143(5):1033-4. PubMed ID: 6206810
[TBL] [Abstract][Full Text] [Related]
17. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.
Himelman RB; Schiller NB
Am J Cardiol; 1989 Feb; 63(5):347-52. PubMed ID: 2464278
[TBL] [Abstract][Full Text] [Related]
18. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients.
Pandya UH; Pellikka PA; Enriquez-Sarano M; Edwards WD; Schaff HV; Connolly HM
J Am Coll Cardiol; 2002 Oct; 40(7):1328-32. PubMed ID: 12383582
[TBL] [Abstract][Full Text] [Related]
19. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.
Bhattacharyya S; Toumpanakis C; Caplin ME; Davar J
Am J Cardiol; 2008 Feb; 101(3):378-81. PubMed ID: 18237604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
